Moderna Among Companies Pledging To Make COVID Vaccine Safety Their Focus

CAMBRIDGE (CBS) -- The CEOs of nine bio-pharma companies, including Moderna in Cambridge, have signed a pledge to maintain "high ethical standards and sound scientific principles" while developing a coronavirus vaccine.

The pledge said the F.D.A. has established clear guidance for vaccine development. Therefore, they will only submit a vaccine for approval or emergency use authorization after it has gone through phase three of a clinical study.

They also promised to create a sufficient supply and a range of options to make the vaccine accessible globally.

The other companies involved include Astra-Zeneca, Johnson & Johnson, BioNTech, GlaxoSmithKline, Merck, Novavax Inc., Pfizer Inc., and Sanofi.

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.